Lonsurf
FDA Approves LONSURF With Bevacizumab for Previously Treated mCRC
The FDA approved trifluridine and tipiracil (LONSURF, Taiho Oncology) with bevacizumab, for previously treated ...
AUGUST 26, 2024
FDA Approves LONSURF With Bevacizumab for Previously Treated Metastatic CRC
The FDA approved trifluridine and tipiracil (LONSURF) with bevacizumab, for metastatic colorectal cancer previously ...
AUGUST 10, 2023
Lonsurf Gets New Indication for Recurrent, Metastatic Gastric and GEJ Cancers
The FDA granted a new indication to Lonsurf for adults with metastatic gastric or GEJ adenocarcinoma previously ...
MARCH 2, 2019
Load more